LONG-TERM EFFECTIVENESS AND SAFETY EVALUATION OF OCRELIZUMAB
Clinical trial NCT05210621 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05210621
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-08
- Primary completion
- 2026-02-24
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.